Search Results - "SHIMADA, KAZUYUKI"

Biology and management of primary effusion lymphoma by Shimada, Kazuyuki, Hayakawa, Fumihiko, Kiyoi, Hitoshi

“…Primary effusion lymphoma (PEL) is a rare B-cell malignancy that most often occurs in immunocompromised patients, such as HIV-infected individuals and patients…”
Get full text

Current progress and future perspectives of research on intravascular large B‐cell lymphoma by Shimada, Kazuyuki, Kiyoi, Hitoshi

“…Intravascular large B‐cell lymphoma is a rare disease of the large B cells characterized by selective growth in the lumina of small vessels in systemic organs…”
Get full text

Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma by Kunou, Shunsuke, Shimada, Kazuyuki, Takai, Mika, Sakamoto, Akihiko, Aoki, Tomohiro, Hikita, Tomoya, Kagaya, Yusuke, Iwamoto, Eisuke, Sanada, Masashi, Shimada, Satoko, Hayakawa, Fumihiko, Oneyama, Chitose, Kiyoi, Hitoshi

“…The tumor microenvironment is deeply involved in the process of tumor growth and development. In this study, we focused on cancer-associated fibroblasts (CAFs)…”
Get full text

Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells by Sakamoto, Akihiko, Kunou, Shunsuke, Shimada, Kazuyuki, Tsunoda, Makoto, Aoki, Tomohiro, Iriyama, Chisako, Tomita, Akihiro, Nakamura, Shigeo, Hayakawa, Fumihiko, Kiyoi, Hitoshi

“…Cancer‐associated fibroblasts (CAF) are a key component in the tumor microenvironment and play functional roles in tumor metastasis and resistance to…”
Get full text

Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan　― Safety and Efficacy of Renal Denervation at 3 Years by Kario, Kazuomi, Yamamoto, Eiichiro, Tomita, Hirofumi, Okura, Takafumi, Saito, Shigeru, Ueno, Takafumi, Yasuhara, Daiki, Shimada, Kazuyuki, on behalf of the SYMPLICITY HTN-Japan Investigators

“…Background: SYMPLICITY HTN-Japan is a prospective, randomized, controlled trial comparing renal denervation (RDN) with standard pharmacologic therapy for…”
Get full text

Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era by Ishikawa, Eri, Nakamura, Masanao, Satou, Akira, Shimada, Kazuyuki, Nakamura, Shotaro

“…Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) typically arises from sites such as the stomach, where there is no…”
Get full text

The Japanese Society of Hypertension Guidelines for Self-monitoring of Blood Pressure at Home (Second Edition) by Imai, Yutaka, Kario, Kazuomi, Shimada, Kazuyuki, Kawano, Yuhei, Hasebe, Naoyuki, Matsuura, Hideo, Tsuchihashi, Takuya, Ohkubo, Takayoshi, Kuwajima, Iwao, Miyakawa, Masaaki

Get full text

Presentation and management of intravascular large B-cell lymphoma by Shimada, Kazuyuki, Dr, Kinoshita, Tomohiro, MD, Naoe, Tomoki, Prof, Nakamura, Shigeo, Prof

“…Summary Intravascular large B-cell lymphoma (IVLBCL) is a rare disease entity of non-Hodgkin lymphoma according to the current WHO classification. This rare…”
Get full text

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas by Kataoka, Keisuke, Miyoshi, Hiroaki, Sakata, Seiji, Dobashi, Akito, Couronné, Lucile, Kogure, Yasunori, Sato, Yasuharu, Nishida, Kenji, Gion, Yuka, Shiraishi, Yuichi, Tanaka, Hiroko, Chiba, Kenichi, Watatani, Yosaku, Kakiuchi, Nobuyuki, Shiozawa, Yusuke, Yoshizato, Tetsuichi, Yoshida, Kenichi, Makishima, Hideki, Sanada, Masashi, Onozawa, Masahiro, Teshima, Takanori, Yoshiki, Yumiko, Ishida, Tadao, Suzuki, Kenshi, Shimada, Kazuyuki, Tomita, Akihiro, Kato, Motohiro, Ota, Yasunori, Izutsu, Koji, Demachi-Okamura, Ayako, Akatsuka, Yoshiki, Miyano, Satoru, Yoshino, Tadashi, Gaulard, Philippe, Hermine, Olivier, Takeuchi, Kengo, Ohshima, Koichi, Ogawa, Seishi

“…Viral infection induces potent cellular immunity and activated intracellular signaling, which may dictate the driver events involved in immune escape and…”
Get full text

Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma by Ishikawa, Eri, Nakamura, Masanao, Shimada, Kazuyuki, Tanaka, Tsutomu, Satou, Akira, Kohno, Kei, Sakakibara, Ayako, Furukawa, Kazuhiro, Yamamura, Takeshi, Miyahara, Ryoji, Nakamura, Shigeo, Kato, Seiichi, Fujishiro, Mitsuhiro

“…Background Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease and the most common gastrointestinal lymphoma. The prognostic/predictive indicators…”
Get full text

Nighttime Home Blood Pressure and the Risk of Hypertensive Target Organ Damage by Ishikawa, Joji, Hoshide, Satoshi, Eguchi, Kazuo, Ishikawa, Shizukiyo, Shimada, Kazuyuki, Kario, Kazuomi

“…In ambulatory blood pressure (BP) monitoring, nighttime BP has a superior ability to predict hypertensive target organ damage than awake BP. We evaluated…”
Get full text

Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients by Kario, Kazuomi, Iwashita, Mikio, Okuda, Yasuyuki, Sugiyama, Mitsunori, Saito, Ikuo, Kushiro, Toshio, Teramukai, Satoshi, Shimada, Kazuyuki

“…SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated the benefit of achieving strict blood pressure control with a lower target blood pressure…”
Get full text

SYMPLICITY HTN-Japan　– First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients by Kario, Kazuomi, Ogawa, Hisao, Okumura, Ken, Okura, Takafumi, Saito, Shigeru, Ueno, Takafumi, Haskin, Russel, Negoita, Manuela, Shimada, Kazuyuki, on behalf of the SYMPLICITY HTN-Japan Investigators

“…Background:SYMPLICITY HTN-Japan is a prospective, randomized, controlled trial comparing renal artery denervation (RDN) with standard pharmacotherapy for…”
Get full text

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma by Shimada, Kazuyuki, Yoshida, Kenichi, Suzuki, Yasuhiro, Iriyama, Chisako, Inoue, Yoshikage, Sanada, Masashi, Kataoka, Keisuke, Yuge, Masaaki, Takagi, Yusuke, Kusumoto, Shigeru, Masaki, Yasufumi, Ito, Takahiko, Inagaki, Yuichiro, Okamoto, Akinao, Kuwatsuka, Yachiyo, Nakatochi, Masahiro, Shimada, Satoko, Miyoshi, Hiroaki, Shiraishi, Yuichi, Chiba, Kenichi, Tanaka, Hiroko, Miyano, Satoru, Shiozawa, Yusuke, Nannya, Yasuhito, Okabe, Asako, Kohno, Kei, Atsuta, Yoshiko, Ohshima, Koichi, Nakamura, Shigeo, Ogawa, Seishi, Tomita, Akihiro, Kiyoi, Hitoshi

“…Intravascular large B-cell lymphoma (IVLBCL) is a unique type of extranodal lymphoma characterized by selective growth of tumor cells in small vessels without…”
Get full text

Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study by Kushiro, Toshio, Kario, Kazuomi, Saito, Ikuo, Teramukai, Satoshi, Sato, Yuki, Okuda, Yasuyuki, Shimada, Kazuyuki

“…The prognostic implications of treated white coat hypertension (WCH) and masked hypertension (MH) in patients with diabetes mellitus (DM) or chronic kidney…”
Get full text

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis by Yokoyama, Mitsuhiro, Dr, Origasa, Hideki, PhD, Matsuzaki, Masunori, MD, Matsuzawa, Yuji, MD, Saito, Yasushi, MD, Ishikawa, Yuichi, MD, Oikawa, Shinichi, MD, Sasaki, Jun, MD, Hishida, Hitoshi, MD, Itakura, Hiroshige, MD, Kita, Toru, MD, Kitabatake, Akira, MD, Nakaya, Noriaki, MD, Sakata, Toshiie, MD, Shimada, Kazuyuki, MD, Shirato, Kunio, MD

“…Summary Background Epidemiological and clinical evidence suggests that an increased intake of long-chain n-3 fatty acids protects against mortality from…”
Get full text

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies by Alduaij, Waleed, Ivanov, Andrei, Honeychurch, Jamie, Cheadle, Eleanor J., Potluri, Sandeep, Lim, Sean H., Shimada, Kazuyuki, Chan, Claude H.T., Tutt, Alison, Beers, Stephen A., Glennie, Martin J., Cragg, Mark S., Illidge, Tim M.

“…The anti-CD20 mAb rituximab has substantially improved the clinical outcome of patients with a wide range of B-cell malignancies. However, many patients…”
Get full text

Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease by Itakura, Hiroshige, Yokoyama, Mitsuhiro, Matsuzaki, Masunori, Saito, Yasushi, Origasa, Hideki, Ishikawa, Yuichi, Oikawa, Shinichi, Sasaki, Jun, Hishida, Hitoshi, Kita, Toru, Kitabatake, Akira, Nakaya, Noriaki, Sakata, Toshiie, Shimada, Kazuyuki, Shirato, Kunio, Matsuzawa, Yuji

“…Aim: The Japan EPA Lipid Intervention Study (JELIS) was the first prospective randomized clinical trial to demonstrate prevention of coronary events by pure…”
Get full text

Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma by Kato, Koji, Makita, Shinichi, Goto, Hideki, Kanda, Junya, Fujii, Nobuharu, Shimada, Kazuyuki, Akashi, Koichi, Izutsu, Koji, Teshima, Takanori, Fukuda, Natsuko, Sumitani, Tokuhito, Sumi, Hiroyuki, Shimizu, Shinji, Kakurai, Yasuyuki, Yoshikawa, Kenji, Tobinai, Kensei, Usui, Noriko, Hatake, Kiyohiko

“…Background Axicabtagene ciloleucel (axi-cel) is an autologous chimeric antigen receptor T-cell based anti-CD19 therapy. The ZUMA-1 study, multicenter,…”
Get full text

A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis by Kato, Koji, Fujii, Nobuharu, Makita, Shinichi, Goto, Hideki, Kanda, Junya, Shimada, Kazuyuki, Akashi, Koichi, Izutsu, Koji, Teshima, Takanori, Fukuda, Natsuko, Sumitani, Tokuhito, Nakamura, Shota, Sumi, Hiroyuki, Shimizu, Shinji, Kakurai, Yasuyuki, Yoshikawa, Kenji, Tobinai, Kensei, Usui, Noriko, Hatake, Kiyohiko

“…Axicabtagene ciloleucel (axi-cel) is an autologous, CD19-targeting chimeric antigen receptor T‑cell therapy. We recently reported the 3-month follow-up results…”
Get full text